Judith L. Swain

Director, Lexicon Pharmaceuticals.

Companies

Lexicon PharmaceuticalsBoard member Sep 26, 2007 to now¹
Prometheus Biosciences, Inc.Board member Mar 11, 2021 to Jun 16, 2023²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Lexicon Pharmaceuticals LXRX174,486 shares³$273.1K at $1.56Jun 3, 2026
Prometheus Biosciences, Inc.0 shares⁴Jun 16, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

Jun 3, 2026Exercised options 89,312 shares of Lexicon Pharmaceuticals³
May 13, 2025Exercised options 36,810 shares of Lexicon Pharmaceuticals⁵
Apr 28, 2024Exercised options 8,032 shares of Lexicon Pharmaceuticals⁶
Jun 16, 2023Returned to company 2,071 shares of Prometheus Biosciences, Inc.⁴
May 21, 2023Exercised options 9,302 shares of Lexicon Pharmaceuticals⁷
May 19, 2023Granted 2,071 shares of Prometheus Biosciences, Inc.⁸
Apr 30, 2022Exercised options 4,024 shares of Lexicon Pharmaceuticals⁹

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARLexicon Pharmaceuticals, Board member
2
SEC EDGARPrometheus Biosciences, Inc., Board member
3
SEC EDGARLexicon Pharmaceuticals shares after the filing of Jun 3, 2026
4
SEC EDGARPrometheus Biosciences, Inc. shares after the filing of Jun 16, 2023
5
SEC EDGARForm 4 filed May 13, 2025
6
SEC EDGARForm 4 filed Apr 29, 2024
7
SEC EDGARForm 4 filed May 22, 2023
8
SEC EDGARForm 4 filed May 19, 2023
9
SEC EDGARForm 4 filed May 2, 2022